Clinical Trial Update: A Phase 4 Study of Regorafenib in Metastatic Colorectal Cancer - Does Educating Physicians Change Patient Outcomes? [Phase 4]

View source ↗

Summary

Phase 4 study assessing whether educating physicians changes patient outcomes in metastatic colorectal cancer patients treated with regorafenib. The trial was t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Regorafenib (Stivarga) (regorafenib)

Snippet

Sponsor: Bayer | Conditions: Physician Education | Phase 4 | Status: TERMINATED | Results posted: 2017-10-19